» Articles » PMID: 19168747

Burkholderia Mallei TssM Encodes a Putative Deubiquitinase That is Secreted and Expressed Inside Infected RAW 264.7 Murine Macrophages

Overview
Journal Infect Immun
Date 2009 Jan 27
PMID 19168747
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Burkholderia mallei, a category B biothreat agent, is a facultative intracellular pathogen that causes the zoonotic disease glanders. The B. mallei VirAG two-component regulatory system activates the transcription of approximately 60 genes, including a large virulence gene cluster encoding a type VI secretion system (T6SS). The B. mallei tssM gene encodes a putative ubiquitin-specific protease that is physically linked to, and transcriptionally coregulated with, the T6SS gene cluster. Mass spectrometry and immunoblot analysis demonstrated that TssM was secreted in a virAG-dependent manner in vitro. Surprisingly, the T6SS was found to be dispensable for the secretion of TssM. The C-terminal half of TssM, which contains Cys and His box motifs conserved in eukaryotic deubiquitinases, was purified and biochemically characterized. Recombinant TssM hydrolyzed multiple ubiquitinated substrates and the cysteine at position 102 was critical for enzymatic activity. The tssM gene was expressed within 1 h after uptake of B. mallei into RAW 264.7 murine macrophages, suggesting that the TssM deubiquitinase is produced in this intracellular niche. Although the physiological substrate(s) is currently unknown, the TssM deubiquitinase may provide B. mallei a selective advantage in the intracellular environment during infection.

Citing Articles

Bacterial esterases reverse lipopolysaccharide ubiquitylation to block host immunity.

Szczesna M, Huang Y, Lacoursiere R, Bonini F, Pol V, Koc F Cell Host Microbe. 2024; 32(6):913-924.e7.

PMID: 38870903 PMC: 11271751. DOI: 10.1016/j.chom.2024.04.012.


Complex Subunit and Glycoconjugate Vaccines and Their Potential to Elicit Cross-Protection to Complex.

Badten A, Torres A Vaccines (Basel). 2024; 12(3).

PMID: 38543947 PMC: 10975474. DOI: 10.3390/vaccines12030313.


The structural basis for deubiquitination by the fingerless USP-type effector TssM.

Hermanns T, Uthoff M, Baumann U, Hofmann K Life Sci Alliance. 2024; 7(2).

PMID: 38170641 PMC: 10719079. DOI: 10.26508/lsa.202302422.


Influence of genomic variations on glanders serodiagnostic antigens using integrative genomic and transcriptomic approaches.

Charron P, Gao R, Chmara J, Hoover E, Nadin-Davis S, Chauvin D Front Vet Sci. 2023; 10:1217135.

PMID: 38125681 PMC: 10730941. DOI: 10.3389/fvets.2023.1217135.


Functional and structural diversity in deubiquitinases of the Chlamydia-like bacterium Simkania negevensis.

Boll V, Hermanns T, Uthoff M, Erven I, Horner E, Kozjak-Pavlovic V Nat Commun. 2023; 14(1):7335.

PMID: 37957213 PMC: 10643670. DOI: 10.1038/s41467-023-43144-y.


References
1.
Barrett A, Rawlings N . Evolutionary lines of cysteine peptidases. Biol Chem. 2001; 382(5):727-33. DOI: 10.1515/BC.2001.088. View

2.
Pickart C, Fushman D . Polyubiquitin chains: polymeric protein signals. Curr Opin Chem Biol. 2004; 8(6):610-6. DOI: 10.1016/j.cbpa.2004.09.009. View

3.
Lin C, Bourque G, Tan P . A comparative synteny map of Burkholderia species links large-scale genome rearrangements to fine-scale nucleotide variation in prokaryotes. Mol Biol Evol. 2007; 25(3):549-58. DOI: 10.1093/molbev/msm282. View

4.
Ulrich R, DeShazer D . Type III secretion: a virulence factor delivery system essential for the pathogenicity of Burkholderia mallei. Infect Immun. 2004; 72(2):1150-4. PMC: 321613. DOI: 10.1128/IAI.72.2.1150-1154.2004. View

5.
Zhou H, Monack D, Kayagaki N, Wertz I, Yin J, Wolf B . Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kappa B activation. J Exp Med. 2005; 202(10):1327-32. PMC: 2212976. DOI: 10.1084/jem.20051194. View